Stock Under $10 with 50-100% upside potential - 14 Days FREE!

6 Stocks at New 52-Week Highs

Stock quotes in this article: SHFL, ABMD, AKRX, SPSC, PLCE, GCA 

Abiomed

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Abiomed (ABMD) is a provider of medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. This stock is trading up 3.5% to $21.33 in recent trading after hitting a 52-week high of $21.50 earlier in the day.

Today's Range: $20.84-$21.50

52-Week Range: $8.97-$21.50

Volume: 153,000

Three-Month Average Volume: 265,486

Abiomed has a market cap of $804 million and an enterprise value of $715 million. This stock trades at a forward price-to-earnings of 125.76. Its estimated growth rate for this year is 78.1%, and for next year it's pegged at 342.9%. The current short interest as a percentage of the float for Abiomed is 6.7%.

From a technical standpoint, ABMD has recently triggered a big breakout trade once the stock cleared some past overhead resistance level at $20.

>>5 Stocks Setting Up to Break Out

Market players should watch for ABMD to continue its trend higher since the stock has held above that key breakout level for a number of trading sessions. As long as ABMD stays above $20 and volume patterns remain decent to strong, then this stock should have a date with $25 in the near future.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs